Assistant Professor, Internal Medicine, Mayo Medical School
Hematology
Dr. Joseph P. Colgan, MD
|
|
Give Review
Joseph P. Colgan practices Hematology. He studied medicine at Harvard Medical School. Harvard Medical School is a one of the best medicals schools. Harvard Medical School has a rank of 1 in research and a 12 in primary care Dr. Joseph P. Colgan is also published. He has 51 publications published. The lastest publication: "Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma.' Joseph Colgan accepts Medicare payments and is listed with Medicare.gov.
Publications
- Large B-cell transformation in nodular lymphocyte predominant Hodgkin Lymphoma: forty-year experience from a single institution.
- Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin Lymphoma.
- Peripheral blood absolute lymphocyte/monocyte ratio during rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment cycles predicts clinical outc...
- Rates and Outcomes of Follicular Lymphoma Transformation in the Immunochemotherapy Era: A Report From the University of Iowa/Mayo Clinic Specialized Program of Researc...
- A phase i trial of immunostimulatory CpG 7909 oligodeoxynucleotide and (90) yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-hodgkin Lymphoma.
- The Absolute Monocyte Count is Associated with Overall Survival in Patients Newly Diagnosed with Follicular Lymphoma.
- Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory Lymphomas.
- A Case of Hairy Cell Leukemia With CCND1-IGH@ Translocation: Indolent Non-nodal Mantle Cell Lymphoma Revisited.
- Elevated serum free light chains are associated with event-free and overall survival in two independent cohorts of patients with diffuse large B-cell Lymphoma.
- Diagnosis and management of Waldenström Macroglobulinemia: Mayo stratification of Macroglobulinemia and risk-adapted therapy (mSMART) guidelines.
- A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin Lymphoma.
- Unusual cutaneous manifestations of B-cell chronic lymphocytic Leukemia.
- mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative Disorders (EBV-LPD).
- A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untr...
- Natural killer/T-cell Lymphoma with ocular and adnexal involvement.
- Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's Lymphoma.
- High-dose intravenous methotrexate followed by autologous stem cell transplantation as a potentially effective therapy for neuroLymphomatosis.
- Breast peau d'orange from large cell Lymphoma.
- Therapeutic options in patients with Lymphoma and severe liver dysfunction.
- Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin Lymphoma.
- The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell Lymphomas.
- Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin''s Lymphoma.
- CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary Central nervous system lymphoma.
- Salvage chemotherapy with rituximab DHAP for relapsed non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group.
- Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular Lymphomas.
- Effectiveness of second line salvage chemotherapy with ifosfamide, carboplatin, and etoposide in patients with relapsed diffuse large B-cell Lymphoma not responding to...
- Absolute lymphocyte count predicts overall survival in follicular Lymphomas.
- The International Prognostic Index predicts outcome after histological transformation of low-grade non-Hodgkin Lymphoma.
- Clinical correlates of distinct immunophenotypic and histologic subcategories of lymphocyte-predominance Hodgkin's Disease.
- Cytogenetic findings in 21 cases of peripheral T-cell Lymphoma.
- Primary Central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy?
- Long-term follow-up of a CHOP-based regimen with maintenance therapy and Central nervous system prophylaxis in lymphoblastic non-Hodgkin''s lymphoma.
- Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell Lymphoma.
- Testicular Lymphoma is associated with a high incidence of extranodal recurrence.
- The consequences of treatment and disease in patients with primary CNS non-Hodgkin's lymphoma: cognitive function and performance status. North Central Cancer Treatmen...
- Rapid immunotyping of B-cell non-Hodgkin's Lymphomas by flow cytometry. A comparison with the standard frozen-section method.
- Patterns of failure in primary testicular non-Hodgkin's Lymphoma.
- The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell Lymphoma.
- Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell Lymphoma.
- A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive Lymphoma.
- Advanced diffuse non-Hodgkin's Lymphoma. Analysis of prognostic factors by the international index and by lactic dehydrogenase in an intergroup study.
- Acute porphyrias: diagnosis and management.
- Rapid S-phase determination of non-Hodgkin's Lymphomas with the use of an immunofluorescence bromodeoxyuridine labeling index procedure.
- Management of subdiaphragmatic early-stage Hodgkin's Disease.
- Clinical trial of recombinant leukocyte A interferon as initial therapy for favorable histology non-Hodgkin's lymphomas and chronic lymphocytic Leukemia. An Eastern Co...
- Cerebral angiotropic large cell Lymphoma (neoplastic angioendotheliosis): therapeutic considerations.
- Treatment of adult Acute lymphocytic leukemia.
- Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's Lymphoma.
- Frentizole therapy of thrombocytopenia in Systemic lupus erythematosus and refractory idiopathic thrombocytopenic purpura.
- Regional density and survival in senile dementia. An interim report on a prospective computed tomographic study.
Procedures Preformed
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Central Nervous System Lymphoma
- Coagulation Disorders (incl. Hemophilia)
- View All
Doctors Specialties
- Hematology
Accepted Insurances
Education
-
Mayo School of Graduate Medical Education -
Harvard Medical School
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1467432468 | |
| NPPES Provider LastName | COLGAN | |
| NPPES Provider FirstName | JOSEPH | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 534.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 24.0 | |
| Percent Opioid Claims | 4.49 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1467432468 |
| Last Name Of The Provider | COLGAN |
| First Name Of The Provider | JOSEPH |
| View All |
Similar Doctors
|
|
Dr. Ivana N M. Micallef, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeremy T. Larsen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gita Thanarajasingam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark R. Litzow, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Thomas M. Habermann, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Jocelin Huang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vilmarie Rodriguez, MD |
|
|
Dr. Syed T. Mahmood, MD |
|
|
Dr. Carrie A. Thompson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Svetomir N. Markovic, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Michelle A. Elliott, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Howard C. Hoagland, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian D. Koh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeremy C. Jones, MD |